UniConnect

The company is integrating its newly purchased LIMS and genome interpretation and reporting capabilities to provide a single platform for cancer and inherited disease diagnostics.

According to Sunquest, UniConnect's technology will augment its own existing solutions for molecular diagnostics.

The deal provides Clinical Genomics with a "cornerstone piece" as it readies its blood-based test for colorectal cancer recurrence for commercialization in the US later this year.

Tute has partnered with LIMS provider UniConnect to build infrastructure to support gene panels for mitochondrial, metabolic, and other genetic diseases.

Tute will provide its cloud-based informatics and genome analysis platform to support two new NGS testing panels that NSO is developing.

NEW YORK (GenomeWeb) – UniConnect said this week that Children's Hospital Colorado's molecular diagnostics laboratory has deployed its Precision Molecular Diagnostics (PMDx) laboratory information system.

NEW YORK (GenomeWeb) — UniConnect last week unveiled PrecisionMDx, a specialized version of its flagship UniFlow laboratory process management software for molecular testing laboratories.

NEW YORK (GenomeWeb) – Utah-based software firm UniConnect said this week that it will donate UniFlow, its laboratory process management software, to George Washington University's Computational Biology Institute (CBI).

Selah Genomics has licensed UniFlow, UniConnect's laboratory information management system, to manage molecular and clinical data for its clinical diagnostic services business.

UniConnect said recently that Dupont Pioneer is using its UniFlow laboratory information management software system to support ongoing efforts to develop new plant products that have higher yields and are more resistant to pests and diseases.

Pages

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.